Sage Therapeutics, Inc.
US ˙ NasdaqGM ˙ US78667J1088
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

SecuritySAGE / Sage Therapeutics, Inc.
InstitutionWolverine Trading, Llc
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Wolverine Trading, Llc ownership in SAGE / Sage Therapeutics, Inc.

On November 14, 2025 - Wolverine Trading, Llc filed a 13F-HR form disclosing ownership of 0 shares of Sage Therapeutics, Inc. (US:SAGE) valued at $0 USD as of September 30, 2025. The entity filed a previous 13F-HR on August 18, 2025 disclosing 18,390 shares of Sage Therapeutics, Inc.. The current value of the position is $0 USD.

Wolverine Trading, Llc has a history of taking positions in derivatives of the underlying security (SAGE) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

SAGE / Sage Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-11-14 2025-09-30 13F SAGE THERAPEUTICS COM 78667J108 0 -100.00 0
2025-08-18 2025-06-30 13F SAGE THERAPEUTICS COM 78667J108 18,390 6,755 58.06 168 75.00 0.0002
2025-05-15 2025-03-31 13F SAGE THERAPEUTICS COM 78667J108 11,635 11,635 96 0.0001
2022-05-16 2022-03-31 13F SAGE THERAPEUTICS COM 78667J108 0 -10,763 -100.00 0 -100.00
2022-02-14 2021-12-31 13F SAGE THERAPEUTICS COM 78667J108 10,763 -4,530 -29.62 465 -31.11 0.0006
2021-11-12 2021-09-30 13F SAGE THERAPEUTICS COM 78667J108 15,293 2,312 17.81 675 -7.79 0.0008
2021-08-06 2021-06-30 13F SAGE THERAPEUTICS COM 78667J108 12,981 -2,769 -17.58 732 -36.57 0.0011
2021-05-14 2021-03-31 13F SAGE THERAPEUTICS COM 78667J108 15,750 9,199 140.42 1,154 98.62 0.0017
2021-02-12 2020-12-31 13F SAGE THERAPEUTICS COM 78667J108 6,551 1,009 18.21 581 75.53 0.0009
2020-11-13 2020-09-30 13F SAGE THERAPEUTICS COM 78667J108 5,542 -580 -9.47 331 29.30 0.0008
2020-08-13 2020-06-30 13F SAGE THERAPEUTICS COM 78667J108 6,122 6,122 256 0.0007
2019-05-15 2019-03-31 13F SAGE THERAPEUTICS COM 78667J108 0 -5,111 -100.00 0 -100.00
2019-02-13 2018-12-31 13F SAGE THERAPEUTICS COM 78667J108 5,111 -3,049 -37.37 455 -60.54 0.0013
2018-11-14 2018-09-30 13F SAGE THERAPEUTICS COM 78667J108 8,160 8,160 1,153 0.0025
2018-05-15 2018-03-31 13F SAGE THERAPEUTICS COM 78667J108 0 -9,798 -100.00 0 -100.00
2018-02-14 2017-12-31 13F SAGE THERAPEUTICS COM 78667J108 9,798 814 9.06 1,614 188.21 0.0058
2017-11-15 2017-09-30 13F SAGE THERAPEUTICS COM 78667J108 8,984 4,004 80.40 560 42.49 0.0021
2017-08-14 2017-06-30 13F SAGE THERAPEUTICS COM 78667J108 4,980 -3,240 -39.42 393 5.08 0.0018
2016-11-14 2016-09-30 13F SAGE THERAPEUTICS COM 78667J108 8,220 6,129 293.11 374 513.11 0.0017
2016-08-15 2016-06-30 13F SAGE THERAPEUTICS COM 78667J108 2,091 2,091 61 0.0003
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-14 2025-09-30 13F SAGE THERAPEUTICS COM Call 0 -100.00 0 n/a n/a n/a
2025-08-18 2025-06-30 13F SAGE THERAPEUTICS COM Call 18,500 169 n/a n/a n/a
2025-05-15 2025-03-31 13F SAGE THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-14 2024-12-31 13F SAGE THERAPEUTICS COM Call 12,400 -35.08 67 -51.80 n/a n/a n/a
2024-11-14 2024-09-30 13F SAGE THERAPEUTICS COM Call 19,100 139 n/a n/a n/a
2024-02-14 2023-12-31 13F SAGE THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-15 2023-09-30 13F SAGE THERAPEUTICS COM Call 13,700 4.58 282 -54.31 n/a n/a n/a
2023-08-23 2023-06-30 13F SAGE THERAPEUTICS COM Call 13,100 -2.24 615 n/a n/a n/a
2023-05-15 2023-03-31 13F SAGE THERAPEUTICS COM Call 13,400 0.00 1 -100.00 n/a n/a n/a
2023-02-14 2022-12-31 13F SAGE THERAPEUTICS COM Call 13,400 -25.14 511 -27.93 n/a n/a n/a
2022-11-14 2022-09-30 13F SAGE THERAPEUTICS COM Call 17,900 24.31 709 50.21 n/a n/a n/a
2022-08-15 2022-06-30 13F SAGE THERAPEUTICS COM Call 14,400 6.67 472 1.94 n/a n/a n/a
2022-05-16 2022-03-31 13F SAGE THERAPEUTICS COM Call 13,500 58.82 463 25.82 n/a n/a n/a
2022-02-14 2021-12-31 13F SAGE THERAPEUTICS COM Call 8,500 -1.16 368 -3.16 n/a n/a n/a
2021-11-12 2021-09-30 13F SAGE THERAPEUTICS COM Call 8,600 -30.65 380 -45.64 n/a n/a n/a
2021-08-06 2021-06-30 13F SAGE THERAPEUTICS COM Call 12,400 77.14 699 36.26 n/a n/a n/a
2021-05-14 2021-03-31 13F SAGE THERAPEUTICS COM Call 7,000 -72.22 513 -77.04 n/a n/a n/a
2021-02-12 2020-12-31 13F SAGE THERAPEUTICS COM Call 25,200 -6.67 2,234 38.67 n/a n/a n/a
2020-11-13 2020-09-30 13F SAGE THERAPEUTICS COM Call 27,000 -0.37 1,611 42.31 n/a n/a n/a
2020-08-13 2020-06-30 13F SAGE THERAPEUTICS COM Call 27,100 -27.54 1,132 2.63 n/a n/a n/a
2020-05-11 2020-03-31 13F SAGE THERAPEUTICS COM Call 37,400 1,103 n/a n/a n/a
2019-05-15 2019-03-31 13F SAGE THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-02-13 2018-12-31 13F SAGE THERAPEUTICS COM Call 21,700 40.91 1,931 -11.22 n/a n/a n/a
2018-11-14 2018-09-30 13F SAGE THERAPEUTICS COM Call 15,400 2,175 n/a n/a n/a
2018-05-15 2018-03-31 13F SAGE THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-02-14 2017-12-31 13F SAGE THERAPEUTICS COM Call 54,400 39.49 8,960 268.72 n/a n/a n/a
2017-11-15 2017-09-30 13F SAGE THERAPEUTICS COM Call 39,000 20.37 2,430 -5.00 n/a n/a n/a
2017-08-14 2017-06-30 13F SAGE THERAPEUTICS COM Call 32,400 63.64 2,558 183.91 n/a n/a n/a
2016-11-14 2016-09-30 13F SAGE THERAPEUTICS COM Call 19,800 901 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-11-15 2023-09-30 13F SAGE THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-08-23 2023-06-30 13F SAGE THERAPEUTICS COM Put 5,000 235 n/a n/a n/a
2022-05-16 2022-03-31 13F SAGE THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-14 2021-12-31 13F SAGE THERAPEUTICS COM Put 19,100 -11.98 826 -13.78 n/a n/a n/a
2021-11-12 2021-09-30 13F SAGE THERAPEUTICS COM Put 21,700 -34.24 958 -48.52 n/a n/a n/a
2021-08-06 2021-06-30 13F SAGE THERAPEUTICS COM Put 33,000 62.56 1,861 25.07 n/a n/a n/a
2021-05-14 2021-03-31 13F SAGE THERAPEUTICS COM Put 20,300 37.16 1,488 13.41 n/a n/a n/a
2021-02-12 2020-12-31 13F SAGE THERAPEUTICS COM Put 14,800 5.71 1,312 57.13 n/a n/a n/a
2020-11-13 2020-09-30 13F SAGE THERAPEUTICS COM Put 14,000 19.66 835 70.76 n/a n/a n/a
2020-08-13 2020-06-30 13F SAGE THERAPEUTICS COM Put 11,700 -64.11 489 -49.17 n/a n/a n/a
2020-05-11 2020-03-31 13F SAGE THERAPEUTICS COM Put 32,600 962 n/a n/a n/a
2019-05-15 2019-03-31 13F SAGE THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-02-13 2018-12-31 13F SAGE THERAPEUTICS COM Put 23,200 4.50 2,065 -34.15 n/a n/a n/a
2018-11-14 2018-09-30 13F SAGE THERAPEUTICS COM Put 22,200 3,136 n/a n/a n/a
2018-05-15 2018-03-31 13F SAGE THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-02-14 2017-12-31 13F SAGE THERAPEUTICS COM Put 82,100 188.07 13,523 661.43 n/a n/a n/a
2017-11-15 2017-09-30 13F SAGE THERAPEUTICS COM Put 28,500 -20.17 1,776 -36.98 n/a n/a n/a
2017-08-14 2017-06-30 13F SAGE THERAPEUTICS COM Put 35,700 21.02 2,818 109.83 n/a n/a n/a
2016-11-14 2016-09-30 13F SAGE THERAPEUTICS COM Put 29,500 1,343 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.